Cargando…
Continous Rituximab treatment for recurrent diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus and antiphosholipid syndrome
Diffuse alveolar hemorrhage (DAH) is a rare but potentially fatal complication in systemic lupus erythematosus (SLE). DAH is typically characterized by hemoptysis, dyspnea, new infiltrates on chest x-rays or CT-scans and a drop in hemoglobin. DAH is seen in less than 2% of patients with SLE and carr...
Autores principales: | Aakjær, Signe, Bendstrup, Elisabeth, Ivarsen, Per, Madsen, Line Bille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633164/ https://www.ncbi.nlm.nih.gov/pubmed/29021954 http://dx.doi.org/10.1016/j.rmcr.2017.09.012 |
Ejemplares similares
-
Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage
por: Montes-Rivera, Gabriela, et al.
Publicado: (2017) -
Systemic lupus erythematosus with diffuse alveolar hemorrhage
por: Huo, Rongxiu, et al.
Publicado: (2023) -
Diffuse Alveolar Hemorrhage in an Undiagnosed Systemic Lupus Erythematosus Patient
por: Salah, Qais M, et al.
Publicado: (2023) -
Strongyloidiasis and Diffuse Alveolar Hemorrhage in a Patient with Systemic Lupus Erythematosus
por: Gonzalez-Ibarra, Fernando, et al.
Publicado: (2014) -
A rare presentation of systemic lupus erythematosus: diffuse alveolar hemorrhage in an infant
por: Ozturk, Kubra, et al.
Publicado: (2014)